Pharmaceutical

Filter

Current filters:

None

Popular Filters

101 to 125 of 7212 results

Endo attempting to outbid Valeant for Salix Pharma

Endo attempting to outbid Valeant for Salix Pharma

12-03-2015

Salix Pharmaceuticals late yesterday confirmed that it has received an unsolicited proposal from Ireland-headquartered…

Endo InternationalMergers & AcquisitionsPharmaceuticalSalix PharmaceuticalsValeant Pharmaceutical International

NICE recommends GSK’s Arzerra for chronic lymphocytic leukemia

NICE recommends GSK’s Arzerra for chronic lymphocytic leukemia

11-03-2015

Confirming an earlier preliminary guidance, medicines cost watchdog for England, the National Institute…

ArzerraGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationUK

EMA publishes document accounting for its pharmacovigilance fees

EMA publishes document accounting for its pharmacovigilance fees

11-03-2015

The European Medicines Agency has published a document accounting for its pharmacovigilance fees.

EMAEuropeEuropean Medicines AgencyPharmaceuticalRegulation

Hikma posts revenue growth of 9% and basic EPS up 30% for 2014

Hikma posts revenue growth of 9% and basic EPS up 30% for 2014

11-03-2015

Jordon-based drugmaker Hikma Pharmaceuticals today reported its preliminary results for the year ended…

FinancialHikma PharmaceuticalsPharmaceutical

Eisai's Halaven to stay on UK Cancer Drugs Fund list pending reconsideration

Eisai's Halaven to stay on UK Cancer Drugs Fund list pending reconsideration

11-03-2015

Japanese drug major Eisai has announced that its drug Halaven (eribulin) will remain on the UK's National…

EisaiHalavenOncologyPharmaceuticalRegulationUK

Pernix to acquire Zohydro ER franchise from Zogenix

11-03-2015

US CNS focused drugmaker Zogenix has entered into a definitive agreement to sell its Zohydro ER (hydrocodone…

Mergers & AcquisitionsNeurologicalPernix TherapeuticsPharmaceuticalZogenixZohydro

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

Ocular Therapeutix reports positive top-line data from Phase III OTX-DP trial

11-03-2015

Biopharma company Ocular Therapeutix has announced positive top-line data from the first of two Phase…

Ocular TherapeutixOphthalmicsPharmaceuticalResearchUSA

AstraZeneca undertakes two-year collaboration with Singaporean organizations for heart failure

AstraZeneca undertakes two-year collaboration with Singaporean organizations for heart failure

11-03-2015

Anglo-Swedish drug major AstraZeneca is to undertake a two-year collaboration with leading organizations…

AstraZenecaCardio-vascularPharmaceuticalResearchSingapore

NICE gives go ahead for Xolair to treat potentially disabling skin condition

NICE gives go ahead for Xolair to treat potentially disabling skin condition

11-03-2015

The medicines cost watchdog the National Institute of Health and Care Excellence (NICE) has recommended…

DermatologicalsNovartisPharmaceuticalPricingRegulationUKXolair

Poor understanding is limiting innovation in pain drug development, says GBI Research

Poor understanding is limiting innovation in pain drug development, says GBI Research

10-03-2015

Limited understanding of pain pathophysiology continues to stand in the way of drug development, and…

AnalgesiaGBIGBI ResearchMarkets & MarketingPharmaceutical

Five-year peak sales forecast of newly-reimbursed drugs in Japan surges

Five-year peak sales forecast of newly-reimbursed drugs in Japan surges

10-03-2015

Despite depreciation of the Japanese yen, the overall output of the Japanese pharmaceutical industry…

JapanMarkets & MarketingPharmaceuticalPharmacologyPricing

Pershing takes nearly 5% of Valeant shares worth $3.3 billion

Pershing takes nearly 5% of Valeant shares worth $3.3 billion

10-03-2015

Capital management firm Pershing Square Holdings has announced a new position in acquisitive Canadian…

FinancialPershing CapitalPharmaceuticalUSAValeant International

FDA updates label on Pfizer's Chantix to warn of interaction with alcohol

FDA updates label on Pfizer's Chantix to warn of interaction with alcohol

10-03-2015

The US Food and Drug Administration has updated the label on Chantix (varenicline), marketed by Pfizer,…

ChantixNeurologicalPfizerPharmaceuticalRegulationUSA

2014 saw highest increase in US drug spend over past decade

2014 saw highest increase in US drug spend over past decade

10-03-2015

In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers…

Anti-viralsFinancialGilead SciencesHarvoniHealthcareJohnson & JohnsonMarkets & MarketingOlysioPharmaceuticalSovaldiUSA

Concordia spends $1.2 billion on Covis Pharma assets

10-03-2015

Canadian pharma and medical devices company Concordia Healthcare Corp has entered into a definitive asset…

Concordia HealthcareCovis PharmaGenericsMergers & AcquisitionsPharmaceutical

Takeda's alogliptin does not increase heart failure risk in type 2 diabetes

Takeda's alogliptin does not increase heart failure risk in type 2 diabetes

10-03-2015

Japan’s largest drugmaker Takeda has published post-hoc analysis of data from the global EXAMINE trial…

alogliptinDiabetesJapanPharmaceuticalResearchTakeda PharmaceuticalsVipidia

Allergy Therapeutics announces share-placing to raise $30 million

Allergy Therapeutics announces share-placing to raise $30 million

10-03-2015

UK-based Allergy Therapeutics has announced a conditional placing of 94,117,650 placing shares to raise…

Allergy TherapeuticsFinancialImmunologicalsPharmaceuticalPollinex Quattro

Sanofi survey shows oncologists' discomfort with UK Cancer Drugs Fund cuts

Sanofi survey shows oncologists' discomfort with UK Cancer Drugs Fund cuts

10-03-2015

More than three quarters of oncologists agree or strongly agree that cuts to the Cancer Drugs Fund in…

JevtanaOncologyPharmaceuticalSanofiSocial IssuesUK

Germany’s IQWiG finds no added benefit for Novartis’ Galvus

Germany’s IQWiG finds no added benefit for Novartis’ Galvus

09-03-2015

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined in a new dossier…

DiabetesGalvusGermanyNovartisPharmaceuticalPricingRegulation

Indian government caught unawares over flu pandemic

Indian government caught unawares over flu pandemic

09-03-2015

The recent outbreak of infections and death caused by the influenza A H1N1 strain across India has turned…

Anti-viralsGlaxoSmithKlineHealthcareIndiaMarkets & MarketingPharmaceuticalPoliticsRelenzaRocheTamiflu

Lycera appoints Jeffrey Wilkins as chief medical officer

09-03-2015

US oncology and autoimmune biopharma company Lycera has appointed Jeffrey Wilkins to the newly-created…

BoardroomBusiness FinanceJeffrey WilkinsLyceraOncologyPharmaceuticalUSAWilkins

Scottish Medicines Consortium approves Gilead's Zydelig and B-MS/Pfizer's Eliquis

Scottish Medicines Consortium approves Gilead's Zydelig and B-MS/Pfizer's Eliquis

09-03-2015

The Scottish Medicines Consortium has approved Zydelig (idelalisib) from Gilead for adult chronic lymphocytic…

EliquisGileadHematologyOncologyPharmaceuticalRegulationUKZydelig

Novo Nordisk's Saxenda achieves clinically meaningful body weight reduction in Phase IIIa SCALET trial

Novo Nordisk's Saxenda achieves clinically meaningful body weight reduction in Phase IIIa SCALET trial

09-03-2015

New data from Danish insulin giant Novo Nordisk has shown that adults with obesity or who are overweight…

DiabetesliraglutideMetabolicsNovo NordiskPharmaceuticalResearch

101 to 125 of 7212 results

Back to top